메뉴 건너뛰기




Volumn 68, Issue 12, 2014, Pages 1462-1466

RS11212617 is associated with metformin treatment response in type 2 diabetes in Shanghai local Chinese population

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; METFORMIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

EID: 84911999571     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12534     Document Type: Article
Times cited : (21)

References (16)
  • 2
    • 12444289448 scopus 로고    scopus 로고
    • Oral antihyperglycemic therapy for type 2 diabetes mellitus
    • Cheng AY, Fantus IG,. Oral antihyperglycemic therapy for type 2 diabetes mellitus. CMAJ 2005; 172: 213-26.
    • (2005) CMAJ , vol.172 , pp. 213-226
    • Cheng, A.Y.1    Fantus, I.G.2
  • 3
    • 13644263258 scopus 로고    scopus 로고
    • Oral antidiabetic agents: Current role in type 2 diabetes mellitus
    • Krentz AJ, Bailey CJ,. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 2005; 65: 385-411.
    • (2005) Drugs , vol.65 , pp. 385-411
    • Krentz, A.J.1    Bailey, C.J.2
  • 4
    • 0033847575 scopus 로고    scopus 로고
    • Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: Evidence for pharmacogenetics in diabetes
    • Pearson ER, Liddell WG, Shepherd M, et al. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes. Diabet Med 2000; 17: 543-5.
    • (2000) Diabet Med , vol.17 , pp. 543-545
    • Pearson, E.R.1    Liddell, W.G.2    Shepherd, M.3
  • 5
    • 84864285795 scopus 로고    scopus 로고
    • Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    • Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012; 55: 1577-96.
    • (2012) Diabetologia , vol.55 , pp. 1577-1596
    • Inzucchi, S.E.1    Bergenstal, R.M.2    Buse, J.B.3
  • 6
    • 0032511566 scopus 로고    scopus 로고
    • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group
    • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 854-65.
    • (1998) Lancet , vol.352 , pp. 854-865
  • 7
    • 79251612707 scopus 로고    scopus 로고
    • Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
    • Zhou K, Bellenguez C, Spencer CC, et al. Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat Genet 2011; 43: 117-20.
    • (2011) Nat Genet , vol.43 , pp. 117-120
    • Zhou, K.1    Bellenguez, C.2    Spencer, C.C.3
  • 8
    • 84866319096 scopus 로고    scopus 로고
    • A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: A replication and meta-Analysis of five cohorts
    • van Leeuwen N, Nijpels G, Becker ML, et al. A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-Analysis of five cohorts. Diabetologia 2012; 55: 1971-7.
    • (2012) Diabetologia , vol.55 , pp. 1971-1977
    • Van, L.N.1    Nijpels, G.2    Becker, M.L.3
  • 9
    • 84865457823 scopus 로고    scopus 로고
    • The C allele of ATM rs11212617 does not associate with metformin response in the Diabetes Prevention Program
    • Florez JC, Jablonski KA, Taylor A, et al. The C allele of ATM rs11212617 does not associate with metformin response in the Diabetes Prevention Program. Diabetes Care 2012; 35: 1864-7.
    • (2012) Diabetes Care , vol.35 , pp. 1864-1867
    • Florez, J.C.1    Jablonski, K.A.2    Taylor, A.3
  • 11
    • 4544246587 scopus 로고    scopus 로고
    • Drug-gene interactions between genetic polymorphisms and antihypertensive therapy
    • Schelleman H, Stricker BH, De Boer A, et al. Drug-gene interactions between genetic polymorphisms and antihypertensive therapy. Drugs 2004; 64: 1801-16.
    • (2004) Drugs , vol.64 , pp. 1801-1816
    • Schelleman, H.1    Stricker, B.H.2    De Boer, A.3
  • 12
    • 34547691356 scopus 로고    scopus 로고
    • Prime suspect: The TCF7L2 gene and type 2 diabetes risk
    • Hattersley AT,. Prime suspect: the TCF7L2 gene and type 2 diabetes risk. J Clin Invest 2007; 117: 2077-9.
    • (2007) J Clin Invest , vol.117 , pp. 2077-2079
    • Hattersley, A.T.1
  • 13
    • 34547702501 scopus 로고    scopus 로고
    • Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes
    • Lyssenko V, Lupi R, Marchetti P, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007; 117: 2155-63.
    • (2007) J Clin Invest , vol.117 , pp. 2155-2163
    • Lyssenko, V.1    Lupi, R.2    Marchetti, P.3
  • 14
    • 38349103468 scopus 로고    scopus 로고
    • Cytochrome P450 2C9 ∗2 and ∗3 polymorphisms and the dose and effect of sulfonylurea in type II diabetes mellitus
    • Becker ML, Visser LE, Trienekens PH, et al. Cytochrome P450 2C9 ∗2 and ∗3 polymorphisms and the dose and effect of sulfonylurea in type II diabetes mellitus. Clin Pharmacol Ther 2008; 83: 288-92.
    • (2008) Clin Pharmacol Ther , vol.83 , pp. 288-292
    • Becker, M.L.1    Visser, L.E.2    Trienekens, P.H.3
  • 15
    • 62749133967 scopus 로고    scopus 로고
    • Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: A preliminary study
    • Becker ML, Visser LE, van Schaik RH, et al. Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study. Diabetes 2009; 58: 745-9.
    • (2009) Diabetes , vol.58 , pp. 745-749
    • Becker, M.L.1    Visser, L.E.2    Van Schaik, R.H.3
  • 16
    • 0031663617 scopus 로고    scopus 로고
    • ATM: From gene to function
    • Rotman G, Shiloh Y,. ATM: from gene to function. Hum Mol Genet 1998; 7: 1555-63.
    • (1998) Hum Mol Genet , vol.7 , pp. 1555-1563
    • Rotman, G.1    Shiloh, Y.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.